Wang Juan, Wang Ning, Gong Fanghua
Department of Ear, Nose, Throat, and Head Neck Surgery (III), Hunan Provincial People's Hospital (The First-Affiliated Hospital of Hunan Normal University), Changsha, Hunan 410016, P.R. China.
Department of Nursing, Hunan Provincial People's Hospital (The First-Affiliated Hospital of Hunan Normal University), Changsha, Hunan 410016, P.R. China.
Exp Ther Med. 2021 Mar;21(3):198. doi: 10.3892/etm.2021.9631. Epub 2021 Jan 8.
The objective of the present review and meta-analysis was to evaluate the efficacy of bupivacaine during tonsillectomy in terms of reducing the mean operative procedure duration, post-operative pain and the onset of post-operative morbidities. The Preferred Reporting Items for Systematic reviews and Meta-Analyses guidelines were followed to perform a systematic literature search using the MEDLINE, Scopus, EMBASE and CENTRAL databases. The present meta-analysis sought to evaluate the efficacy of bupivacaine administered during tonsillectomy as compared to the administration of normal saline. The efficacy of the intervention was evaluated based on pain scores using the visual analogue scale, the duration of the operation and the occurrence of post-operative morbidities. Out of 1,427 records, 15 articles with 729 participants (mean age, 10.2±6.7 years) were included in the study. The present systematic review supported the use of bupivacaine during tonsillectomy at a level of evidence of 1b and confirmed beneficial effects of bupivacaine intervention by demonstrating small to large effect reductions in the visual analog scale score (Hedge's g, -1.48), the mean duration of the operative procedure (Hedge's g, -1.35) and the incidence of post-operative morbidity (Hedge's g, -0.23) in comparison to the placebo groups treated with normal saline. Based on these results, the administration of bupivacaine is recommended during tonsillectomies to reduce the perceived level of pain, the duration of the operation and the post-operative morbidity.
本综述和荟萃分析的目的是评估布比卡因在扁桃体切除术中的疗效,包括缩短平均手术时间、减轻术后疼痛以及降低术后并发症的发生率。我们遵循系统评价和荟萃分析的首选报告项目指南,使用MEDLINE、Scopus、EMBASE和CENTRAL数据库进行系统的文献检索。本荟萃分析旨在评估扁桃体切除术中使用布比卡因与使用生理盐水相比的疗效。根据视觉模拟量表的疼痛评分、手术时间和术后并发症的发生情况来评估干预措施的疗效。在1427条记录中,有15篇文章共729名参与者(平均年龄10.2±6.7岁)被纳入研究。本系统评价支持在扁桃体切除术中使用布比卡因,证据等级为1b,并通过证明与使用生理盐水的安慰剂组相比,布比卡因干预在视觉模拟量表评分(Hedge's g,-1.48)、平均手术时间(Hedge's g,-1.35)和术后并发症发生率(Hedge's g,-0.23)方面有大小不等的效应降低,证实了布比卡因干预的有益效果。基于这些结果,建议在扁桃体切除术中使用布比卡因,以降低疼痛程度、缩短手术时间并减少术后并发症。